188 related articles for article (PubMed ID: 28484461)
1. Blockade of Neutrophil's Chemokine Receptors CXCR1/2 Abrogate Liver Damage in Acute-on-Chronic Liver Failure.
Khanam A; Trehanpati N; Riese P; Rastogi A; Guzman CA; Sarin SK
Front Immunol; 2017; 8():464. PubMed ID: 28484461
[TBL] [Abstract][Full Text] [Related]
2. Low expression of CXCR1/2 on neutrophils predicts poor survival in patients with hepatitis B virus-related acute-on-chronic liver failure.
Xu R; Bao C; Huang H; Lin F; Yuan Y; Wang S; Jin L; Yang T; Shi M; Zhang Z; Wang FS
Sci Rep; 2016 Dec; 6():38714. PubMed ID: 27974825
[TBL] [Abstract][Full Text] [Related]
3. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
[TBL] [Abstract][Full Text] [Related]
4. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
[TBL] [Abstract][Full Text] [Related]
5. Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2.
Feniger-Barish R; Ran M; Zaslaver A; Ben-Baruch A
Cytokine; 1999 Dec; 11(12):996-1009. PubMed ID: 10623425
[TBL] [Abstract][Full Text] [Related]
6. [Influence of IFN on expression of chemokine receptor CXCR1, CXCR2 and their ligand IL-8 in the patients with chronic hepatitis B].
Bi HJ; Wang J; Huang HS; Liu JH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):422-5. PubMed ID: 22482416
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-8 promotes cell migration via CXCR1 and CXCR2 in liver cancer.
Bi H; Zhang Y; Wang S; Fang W; He W; Yin L; Xue Y; Cheng Z; Yang M; Shen J
Oncol Lett; 2019 Oct; 18(4):4176-4184. PubMed ID: 31516616
[TBL] [Abstract][Full Text] [Related]
9. Bronchoepithelial expression of CXCR1 and CXCR2 does not facilitate transepithelial migration of neutrophils.
Schulz C; Stoelcker B; Ruhland B; Jentsch N; Steege A
Respiration; 2012; 84(2):108-16. PubMed ID: 22076427
[TBL] [Abstract][Full Text] [Related]
10. Pathological neutrophil migration predicts adverse outcomes in hospitalized patients with liver cirrhosis.
Langer MM; Sichelschmidt S; Bauschen A; Bornemann L; Guckenbiehl S; Gunzer M; Lange CM
Liver Int; 2023 Apr; 43(4):896-905. PubMed ID: 36440606
[TBL] [Abstract][Full Text] [Related]
11. The collagen-breakdown product N-acetyl-Proline-Glycine-Proline (N-alpha-PGP) does not interact directly with human CXCR1 and CXCR2.
de Kruijf P; Lim HD; Overbeek SA; Zaman GJ; Kraneveld AD; Folkerts G; Leurs R; Smit MJ
Eur J Pharmacol; 2010 Sep; 643(1):29-33. PubMed ID: 20599927
[TBL] [Abstract][Full Text] [Related]
12. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis.
Zimmermann HW; Seidler S; Gassler N; Nattermann J; Luedde T; Trautwein C; Tacke F
PLoS One; 2011; 6(6):e21381. PubMed ID: 21731723
[TBL] [Abstract][Full Text] [Related]
14. Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways.
Pignatti P; Moscato G; Casarini S; Delmastro M; Poppa M; Brunetti G; Pisati P; Balbi B
J Allergy Clin Immunol; 2005 Jan; 115(1):88-94. PubMed ID: 15637552
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats.
Barsante MM; Cunha TM; Allegretti M; Cattani F; Policani F; Bizzarri C; Tafuri WL; Poole S; Cunha FQ; Bertini R; Teixeira MM
Br J Pharmacol; 2008 Mar; 153(5):992-1002. PubMed ID: 17891165
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-23 mediates the pathogenesis of LPS/GalN-induced liver injury in mice.
Bao S; Zhao Q; Zheng J; Li N; Huang C; Chen M; Cheng Q; Zhu M; Yu K; Liu C; Shi G
Int Immunopharmacol; 2017 May; 46():97-104. PubMed ID: 28282579
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of neutrophil chemokine responses in trauma patients at risk for pneumonia.
Tarlowe MH; Duffy A; Kannan KB; Itagaki K; Lavery RF; Livingston DH; Bankey P; Hauser CJ
Am J Respir Crit Care Med; 2005 Apr; 171(7):753-9. PubMed ID: 15618463
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis.
Cummings CJ; Martin TR; Frevert CW; Quan JM; Wong VA; Mongovin SM; Hagen TR; Steinberg KP; Goodman RB
J Immunol; 1999 Feb; 162(4):2341-6. PubMed ID: 9973513
[TBL] [Abstract][Full Text] [Related]
19. LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2.
Aul R; Patel S; Summerhill S; Kilty I; Plumb J; Singh D
Int Immunopharmacol; 2012 Jul; 13(3):225-31. PubMed ID: 22561413
[TBL] [Abstract][Full Text] [Related]
20. A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist.
Nicholson GC; Tennant RC; Carpenter DC; Sarau HM; Kon OM; Barnes PJ; Salmon M; Vessey RS; Tal-Singer R; Hansel TT
Pulm Pharmacol Ther; 2007; 20(1):52-9. PubMed ID: 16406722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
